Plasma neurofilament light chain (NfL) concentrations have shown an excellent diagnostic and prognostic performance for symptomatic AD in DS and have been proposed as plasma biomarkers (Carmona-Iragui et al., 2021). The gene discussed is NEFL; the disease is Dravet syndrome.